<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>PURPOSE: To investigate the role of the <z:chebi fb="3" ids="16335">adenosine</z:chebi> A1 receptor in the rapid tolerance to <z:hpo ids='HP_0002637'>cerebral ischemia</z:hpo> induced by <z:chebi fb="0" ids="6015">isoflurane</z:chebi> preconditioning </plain></SENT>
<SENT sid="1" pm="."><plain>METHODS: Seventy-five rats were randomly assigned into five groups (n = 15 each): Control, 8-<z:chebi fb="0" ids="52880">cyclopentyl</z:chebi>-1,3-dipropulxanthine (DPCPX), <z:chebi fb="0" ids="6015">Isoflurane</z:chebi>, DPCPX+<z:chebi fb="0" ids="6015">Isoflurane</z:chebi> and Vehicle+<z:chebi fb="0" ids="6015">Isoflurane</z:chebi> groups </plain></SENT>
<SENT sid="2" pm="."><plain><z:hpo ids='HP_0000001'>All</z:hpo> animals underwent right middle cerebral <z:mp ids='MP_0006134'>artery occlusion</z:mp> (MCAO) for two hours </plain></SENT>
<SENT sid="3" pm="."><plain><z:chebi fb="0" ids="6015">Isoflurane</z:chebi> preconditioning was conducted one hour before MCAO in <z:chebi fb="0" ids="6015">Isoflurane</z:chebi>, DPCPX+<z:chebi fb="0" ids="6015">Isoflurane</z:chebi> and Vehicle+<z:chebi fb="0" ids="6015">Isoflurane</z:chebi> groups by exposing the animals to 1.5% <z:chebi fb="0" ids="6015">isoflurane</z:chebi> in 98% oxygen for one hour </plain></SENT>
<SENT sid="4" pm="."><plain>In the Control and DPCPX groups, animals were exposed to 98% oxygen one hour before MCAO for one hour </plain></SENT>
<SENT sid="5" pm="."><plain>A selective <z:chebi fb="3" ids="16335">adenosine</z:chebi> A1 receptor <z:chebi fb="68" ids="48706">antagonist</z:chebi>, DPCPX, was administered (0.1 mg x kg(-1)) 15 min before <z:chebi fb="0" ids="6015">isoflurane</z:chebi>/oxygen exposure in the DPCPX and DPCPX+<z:chebi fb="0" ids="6015">Isoflurane</z:chebi> groups to evaluate the effect of <z:chebi fb="3" ids="16335">adenosine</z:chebi> A1 receptor <z:chebi fb="68" ids="48706">antagonist</z:chebi> on <z:chebi fb="0" ids="6015">isoflurane</z:chebi> preconditioning </plain></SENT>
<SENT sid="6" pm="."><plain><z:chebi fb="0" ids="28262">Dimethyl sulfoxide</z:chebi>, the solvent of DPCPX, was administered (1 mL x kg(-1)) 15 min before <z:chebi fb="0" ids="6015">isoflurane</z:chebi> exposure in the Vehicle+<z:chebi fb="0" ids="6015">Isoflurane</z:chebi> group </plain></SENT>
<SENT sid="7" pm="."><plain>Neurological deficit scores and brain <z:mpath ids='MPATH_124'>infarct</z:mpath> volumes were evaluated 24 hr after reperfusion </plain></SENT>
<SENT sid="8" pm="."><plain>RESULTS: Animals in the <z:chebi fb="0" ids="6015">Isoflurane</z:chebi> and Vehicle+<z:chebi fb="0" ids="6015">Isoflurane</z:chebi> groups developed lower neurological deficit scores and smaller brain <z:mpath ids='MPATH_124'>infarct</z:mpath> volumes than the Control group (P &lt; 0.01) </plain></SENT>
<SENT sid="9" pm="."><plain>Animals in the DPCPX+<z:chebi fb="0" ids="6015">Isoflurane</z:chebi> group developed higher neurological deficit scores and larger brain <z:mpath ids='MPATH_124'>infarct</z:mpath> volumes than the <z:chebi fb="0" ids="6015">Isoflurane</z:chebi> and Vehicle+<z:chebi fb="0" ids="6015">Isoflurane</z:chebi> groups (P &lt; 0.01) </plain></SENT>
<SENT sid="10" pm="."><plain>CONCLUSION: The present study demonstrates that preconditioning with <z:chebi fb="0" ids="6015">isoflurane</z:chebi> reduces focal cerebral ischemic injury in rats, and the <z:chebi fb="3" ids="16335">adenosine</z:chebi> A1 receptor <z:chebi fb="68" ids="48706">antagonist</z:chebi> (DPCPX) attenuates the neuroprotection induced by <z:chebi fb="0" ids="6015">isoflurane</z:chebi> preconditioning </plain></SENT>
</text></document>